Long-term outcomes of abandoned leads of cardiac implantable electronic devices

Soonil Kwon1, Euijae Lee2, Eue-Keun Choi3

  • 1Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.

Heart Rhythm
|August 5, 2023
PubMed

Insights

Long-term outcomes for abandoned leads (ALs) in cardiac implantable electronic devices (CIEDs) show single ALs pose similar risks to no ALs. However, multiple ALs significantly increase risks of infection and all-cause mortality in CIED patients.

Area of Science:

  • Cardiology
  • Biomedical Engineering

Background:

  • Long-term outcomes of abandoned leads (ALs) in patients with cardiac implantable electronic devices (CIEDs) are not well-documented.
  • Understanding these outcomes is crucial for managing patients with CIEDs.

Purpose of the Study:

  • To investigate the long-term clinical outcomes associated with abandoned leads in patients with CIEDs.
  • To compare the risks of CIED-related infection, venous thrombosis/stenosis, and all-cause mortality between patients with and without ALs.

Main Methods:

  • Retrospective cohort study of 2962 CIED procedures from 1984-2018.
  • 130 patients with ALs were matched with 260 controls without ALs.
  • Cox proportional hazard models were used to compare outcomes.

Main Results:

  • Mean follow-up was 11.2 years.
  • Lead malfunction was the most common reason for abandonment (64.6%).
  • While single ALs showed no significant difference in risks, multiple ALs were associated with increased risks of infection (aHR 8.61) and all-cause mortality (aHR 2.42).

Conclusions:

  • Single abandoned leads (ALs) in cardiac implantable electronic devices (CIEDs) do not appear to increase long-term risks of infection, venous thrombosis/stenosis, or all-cause mortality compared to no ALs.
  • Multiple ALs are associated with significantly higher risks of CIED-related infection and all-cause mortality.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
16
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
8
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11